Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Anti-angiogenic properties of a sulindac analogue
A. Pyriochou
, S. Tsigkos
, T. Vassilakopoulos
, T. Cottin
, Z. Zhou
, E. Gourzoulidou
, C. Roussos
, H. Waldmann
, A. Giannis
, A. Papapetropoulos
Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-angiogenic properties of a sulindac analogue'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Angiopoietin Receptor
100%
Angiopoietin 1
100%
Antiangiogenic
100%
Sulindac
100%
Vasculotropin
66%
Growth Factor
33%
Receptor
33%
Phosphotransferase
33%
Mitogen Activated Protein Kinase
33%
Fibrinogen
33%
Potassium Acetate
33%
Fibroblast Growth Factor 2
33%
Protein Kinase B
33%
Matrigel
33%
Neovascularization (Pathology)
33%
Angiopoietin
33%
Keyphrases
Antiangiogenic Properties
100%
C-18
100%
Sulindac Analogues
100%
Angiopoietin
40%
Tie-2 Receptor
30%
Incubation
20%
Human Umbilical Vein Endothelial Cells (HUVECs)
20%
Vascular Endothelial Cell Growth Factor
20%
Signaling Pathway
10%
Growth Factors
10%
Endothelial Cells
10%
Mitogen-activated Protein Kinase
10%
Induced Response
10%
Transendothelial Migration
10%
Concentration-dependent
10%
Bromo
10%
Methyl
10%
Neovascularization
10%
Acetic Acid
10%
Induced Proliferation
10%
Kinase Assay
10%
Receptor Activity
10%
Matrigel
10%
New Blood Vessel
10%
Chicken Chorioallantoic Membrane
10%
Kinase Family
10%
Blood Vessel Formation
10%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
10%
Angiogenesis Inhibitors
10%
Receptor Phosphorylation
10%
MTT Assay
10%
Migration Assay
10%
Boyden Chamber
10%
Structure Formation
10%
Benzylidene
10%
Dose-dependent
10%
Fibroblast Growth Factor 2 (FGF2)
10%
Tube Shapes
10%
In Vitro Experiments
10%